Federal Circuit Upholds Bench Trial Outcome In Drug Patent Dispute
WASHINGTON, N.J. — A New Jersey federal judge’s determination that three patents relating to an extended release seizure medication are not invalid and would be infringed by a proposed generic drug...To view the full article, register now.
Already a subscriber? Click here to view full article